Bringing Cuban Biotech Research to bear on COVID-19: all hands and minds on deck

Lila Castellanos-Serra

2020, Number 2

<< Back Next >>

MEDICC Review 2020; 22 (2)

Bringing Cuban Biotech Research to bear on COVID-19: all hands and minds on deck

Castellanos-Serra L

Full text

How to cite this article

Language: English
References: 0
Page: 31-37
PDF size: 191.82 Kb.

Text Extraction

This MEDICC Review roundtable gathers some of Cuba’s top researchers in the fi elds of vaccines and biotechnology, all of whom work in institutions belonging to BioCubaFarma, the umbrella company of Cuban biotech and pharmaceutical R&D, production, distribution and export. Founded in 2012, the company is comprised of 34 enterprises with 61 lines of production and some 20,000 employees. A total of 765 of its products are registered in 53 countries and exported to another 50. Its scientists’ research has resulted in 2640 patents in Cuba and globally.